Who
Daniel Vitt
Director
Company insider
Files Form 4 as: CEO and Director, Immunic.
In numbers
- Trades disclosed
- 31
- Buys
- 6
- Sells
- 2
- Bought
- $77K
- Sold
- $93K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Aug 2019
- Last trade
- 29 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jun 2026filed 29 Jun 2026 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —445,000 at $0.00 | filing |
| 29 Jun 2026filed 29 Jun 2026 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —445,000 at $0.00 | filing |
| 16 Jul 2025filed 18 Jul 2025 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —860,000 at $0.00 | filing |
| 16 Jul 2025filed 18 Jul 2025 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,720,000 at $0.00 | filing |
| 16 Jul 2025filed 18 Jul 2025 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,720,000 at $0.00 | filing |
| 16 Jul 2025filed 18 Jul 2025 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —860,000 at $0.00 | filing |
| 16 Jul 2025filed 18 Jul 2025 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —860,000 at $0.00 | filing |
| 5 Jun 2025filed 20 Jun 2025 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,558,000 at $0.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,535,000 at $0.00 | filing |
| 4 Jun 2025filed 20 Jun 2025 | IMUX ImmunicBiotechnology | SEC FORM 4 Bought | $12K15,000 at $0.77 | filing |
| 4 Jun 2025filed 6 Jun 2025 | IMUX ImmunicBiotechnology | SEC FORM 4 Bought | $12K15,000 at $0.77 | filing |
| 4 Dec 2024filed 6 Dec 2024 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —820,000 at $0.00 | filing |
| 4 Mar 2024filed 6 Mar 2024 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code D | —65,000 | filing |
| 4 Mar 2024filed 6 Mar 2024 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code D | —80,000 | filing |
| 4 Mar 2024filed 6 Mar 2024 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code D | —115,000 | filing |
| 4 Mar 2024filed 6 Mar 2024 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code D | —215,000 | filing |
| 4 Mar 2024filed 6 Mar 2024 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,000 | filing |
| 4 Mar 2024filed 6 Mar 2024 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —485,000 | filing |
| 26 Feb 2024filed 28 Feb 2024 | IMUX ImmunicBiotechnology | SEC FORM 4 Bought | $18K14,000 at $1.31 | filing |
| 17 Jan 2024filed 19 Jan 2024 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,160,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.